A Hugill1, K Shimomura, F M Ashcroft, R D Cox. 1. Metabolism and Inflammation, MRC Harwell Mammalian Genetics Unit, Harwell Science and Innovation Campus, Harwell, OX11 0RD, UK.
Abstract
AIMS/HYPOTHESIS: We identified a mouse with a point mutation (Y12STOP) in the Kcnj11 subunit of the K(ATP) channel. This point mutation is identical to that found in a patient with congenital hyperinsulinism of infancy (HI). We aimed to characterise the phenotype arising from this loss-of-function mutation and to compare it with that of other mouse models and patients with HI. METHODS: We phenotyped an N-ethyl-N-nitrosourea-induced mutation on a C3H/HeH background (Kcnj11 ( Y12STOP )) using intraperitoneal glucose tolerance testing to measure glucose and insulin plasma concentrations. Insulin secretion and response to incretins were measured on isolated islets. RESULTS: Homozygous male and female adult Kcnj11 ( Y12STOP ) mice exhibited impaired glucose tolerance and a defect in insulin secretion as measured in vivo and in vitro. Islets had an impaired incretin response and reduced insulin content. CONCLUSIONS/ INTERPRETATION: The phenotype of homozygous Kcnj11 ( Y12STOP ) mice is consistent with that of other Kcnj11-knockout mouse models. In contrast to the patient carrying this mutation homozygously, the mice studied did not have hyperinsulinaemia or hypoglycaemia. It has been reported that HI patients may develop diabetes and our mouse model may reflect this clinical feature. The Kcnj11 ( Y12STOP ) model may thus be useful in further studies of K(ATP) channel function in various cell types and in investigation of the development of hyperglycaemia in HI patients.
AIMS/HYPOTHESIS: We identified a mouse with a point mutation (Y12STOP) in the Kcnj11 subunit of the K(ATP) channel. This point mutation is identical to that found in a patient with congenital hyperinsulinism of infancy (HI). We aimed to characterise the phenotype arising from this loss-of-function mutation and to compare it with that of other mouse models and patients with HI. METHODS: We phenotyped an N-ethyl-N-nitrosourea-induced mutation on a C3H/HeH background (Kcnj11 ( Y12STOP )) using intraperitoneal glucose tolerance testing to measure glucose and insulin plasma concentrations. Insulin secretion and response to incretins were measured on isolated islets. RESULTS: Homozygous male and female adult Kcnj11 ( Y12STOP ) mice exhibited impaired glucose tolerance and a defect in insulin secretion as measured in vivo and in vitro. Islets had an impaired incretin response and reduced insulin content. CONCLUSIONS/ INTERPRETATION: The phenotype of homozygous Kcnj11 ( Y12STOP ) mice is consistent with that of other Kcnj11-knockout mouse models. In contrast to the patient carrying this mutation homozygously, the mice studied did not have hyperinsulinaemia or hypoglycaemia. It has been reported that HI patients may develop diabetes and our mouse model may reflect this clinical feature. The Kcnj11 ( Y12STOP ) model may thus be useful in further studies of K(ATP) channel function in various cell types and in investigation of the development of hyperglycaemia in HI patients.
Authors: J C Koster; M S Remedi; T P Flagg; J D Johnson; K P Markova; B A Marshall; C G Nichols Journal: Proc Natl Acad Sci U S A Date: 2002-12-16 Impact factor: 11.205
Authors: M S Remedi; J V Rocheleau; A Tong; B L Patton; M L McDaniel; D W Piston; J C Koster; C G Nichols Journal: Diabetologia Date: 2006-08-19 Impact factor: 10.122
Authors: Maria S Remedi; Joseph C Koster; Kamelia Markova; Susumu Seino; Takashi Miki; Brian L Patton; Michael L McDaniel; Colin G Nichols Journal: Diabetes Date: 2004-12 Impact factor: 9.461
Authors: T Miki; K Nagashima; F Tashiro; K Kotake; H Yoshitomi; A Tamamoto; T Gonoi; T Iwanaga; J Miyazaki; S Seino Journal: Proc Natl Acad Sci U S A Date: 1998-09-01 Impact factor: 11.205
Authors: Mohamed Mohideen Quwailid; Alison Hugill; Neil Dear; Lucie Vizor; Sara Wells; Emma Horner; Shelly Fuller; Jessica Weedon; Hamish McMath; Paul Woodman; David Edwards; David Campbell; Susan Rodger; Joanne Carey; Ann Roberts; Pete Glenister; Zuzanna Lalanne; Nick Parkinson; Emma L Coghill; Richard McKeone; Sam Cox; John Willan; Andy Greenfield; David Keays; Saffron Brady; Nigel Spurr; Ian Gray; Jackie Hunter; Steve D M Brown; Roger D Cox Journal: Mamm Genome Date: 2004-08 Impact factor: 2.957
Authors: Colin A Leech; Igor Dzhura; Oleg G Chepurny; Guoxin Kang; Frank Schwede; Hans-G Genieser; George G Holz Journal: Prog Biophys Mol Biol Date: 2011-07-19 Impact factor: 3.667
Authors: Kenju Shimomura; Maija Tusa; Michaela Iberl; Melissa F Brereton; Stephan Kaizik; Peter Proks; Carolina Lahmann; Nagendra Yaluri; Shalem Modi; Hanna Huopio; Jarkko Ustinov; Timo Otonkoski; Markku Laakso; Frances M Ashcroft Journal: Diabetes Date: 2013-07-31 Impact factor: 9.461